Tetanus Immune Globulin
- Atc Codes:J07AM52
Table of contents
- Brand Names
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Warnings and Precautions
- Adverse Reactions
- Drug Interactions
- Dosage
- Special Considerations
Brand Names
Europe
Austria: Tetabulin S/D, Tetagam P; Belgium: Tetabuline S/D; Czech Republic: Tetabulin S/D; Germany: Tetagam P, Tetanobulin S/D; Greece: Igantet, Tetagam-P; Ireland: Tetabulin; Italy: Gamma-Tet P, Igantet, Tetabulin, Tetanus Gamma; Luxembourg: Tetabuline; Malta: Human Tetanus Immunoglobulin, Tetabulin S/D; Poland: Igantet, Tetabulin S/D, Tetaglobulin; Portugal: Gamaglobulina Humana Antitetânica, Tetagam P, Tetanus-Gamma; Romania: Tetagam, Tetig 500; Spain: Tetagamma.
North America
Canada: HyperTET S/D; USA: HyperTET S/D.
Latin America
Argentina: Gamma Antitetánica, Igantet; Brazil: Tetanogamma.
Asia
Japan: Tetagam.
Drug combinations
Chemistry
Pharmacologic Category
Serums, Toxoids, and Vaccines; Serums. Immune Globulin. (ATC-Code: J07AM52).
Mechanism of action
Passive immunity toward tetanus.
Therapeutic use
Prophylaxis against tetanus following injury in patients where immunization status is unknown or uncertain.
Pregnancy and lactiation implications
Animal reproduction studies not conducted to date.
Unlabeled use
Contraindications
Warnings and precautions
Hypersensitivity and anaphylactic reactions can occur. Use with caution in isolated immunoglobulin A deficiency, or history of systemic hypersensitivity to human immunoglobulins; also in thrombocytopenia or coagulation disorders (I.M. injections may be contraindicated). Product of human plasma (may potentially contain infectious agents which could transmit disease). Not for intravenous administration.